董事
Appajosyula Sireesh is a director at Hepion Pharmaceuticals, Inc. (HEPA), appointed to the Board on March 16, 2026.[[2]](https://au.marketscreener.com/news/hepion-pharmaceuticals-inc-announces-board-appointments-ce7e5ed2db8ef423)[[4]](https://www.stocktitan.net/sec-filings/CTRVP/form-3-hepion-pharmaceuticals-inc-initial-statement-of-beneficial-own-57f6b7dce882.html) His address is listed as c/o Hepion Pharmaceuticals, Inc., 34 Shrewsbury Ave., Suite 1D, Red Bank, New Jersey 07701.[[3]](https://www.otcmarkets.com/filing/xls?id=19265194&guid=0UI-kpU9Hz3Yh3h)[[4]](https://www.stocktitan.net/sec-filings/CTRVP/form-3-hepion-pharmaceuticals-inc-initial-statement-of-beneficial-own-57f6b7dce882.html)
On April 21, 2026, Sireesh purchased 1,250,000 shares of Hepion Pharmaceuticals common stock in an open-market transaction at $0.04 per share, totaling $50,000, establishing his direct ownership at 1,250,000 shares.[[1]](https://www.stocktitan.net/sec-filings/HEPA/form-4-hepion-pharmaceuticals-inc-insider-trading-activity-c405096adb2a.html)[[7]](https://hepionpharma.com/investors/filings/) This followed his initial Form 3 filing on March 16, 2026, which reported no prior transactions or beneficial ownership.[[4]](https://www.stocktitan.net/sec-filings/CTRVP/form-3-hepion-pharmaceuticals-inc-initial-statement-of-beneficial-own-57f6b7dce882.html)[[5]](https://www.streetinsider.com/news.php?id=26186330&classic=1)
查看完整内部人档案 →